PhoP is part of a two-component regulatory system, which we have previously demonstrated in Neisseria meningitidis and shown to be an important regulator of virulence in an in vivo model. The phoP mutant clearly induced cross-species reactive antibodies and lacks the obvious toxic effects of the wild-type strain. In the current study, we demonstrate distinct differences between the wild-type and mutant strains in an in vitro model of toxicity. At concentrations likely to be present early in an infection, the mutant was more efficient at stimulating an inflammatory response than the wild-type. However, at the concentrations likely to be found at the site of a fulminant infection, the mutant showed significantly weaker ability to stimulate the release of pro-inflammatory cytokines and the production of reactive oxygen and nitrogen intermediates. SDS-PAGE analysis of the isolated LOS from the wild-type and mutant showed a difference in the level of expression of two major species of LOS, a finding which was supported by preliminary MALDI-TOF analysis. These results suggest that the altered toxicity of the mutant may be due to the increased expression of a conformationally altered LOS species, which shows less affinity and avidity for the cellular receptors responsible for the inflammatory response to endotoxin.
INTRODUCTION
Neisseria meningitidis is the major cause of epidemic meningitis world-wide and failure to recognize and treat the symptoms promptly can lead to toxic shock and ultimately death within a few hours. 1, 2 A critical virulence factor in N. meningitidis infection is lipo-oligosaccharide (LOS). It is the predominant glycolipid of the outer membrane and, in neisseria, comprises an outer core with variable oligosaccharide composition, a conserved inner core with two heptoses linked to two 2-keto-3-deoxyoctulosinic acid (Kdo) sugars and lipid A. The latter is found in many Gram-negative bacteria and is known to be responsible for many of the toxic effects observed during infection. [3] [4] [5] [6] [7] [8] However, the lipid A in N. meningitidis is distinct from that in other organisms (such as Escherichia coli) in that it comprises a β-1′,6-linked disaccharide of glucosamine acylated with β-hydroxymyristates (2-and 2′ positions) and β-hydroxylaurates (3-and 3′-positions). In addition, acyloxyacyl linked laurate residues are located at the 2-and 2′-positions. 9 The structure of LPS or LOS has been shown clearly to influence the toxicity of the molecule. 10 Extensive work using a range of micro-organisms has demonstrated that more than 30 genes are involved in the biosynthesis of endotoxin. 8 The transcription of a number of these is controlled by a two-component regulatory system, phoP/phoQ. [11] [12] [13] This system has been extensively investigated in Salmonella spp. where it has been shown to affect more than 40 different genes, termed phoP-activated (pag) and phoP-repressed (prg) genes. phoP/phoQ responsive genes have been shown to regulate the acylation/deacylation of the lipid A component of LPS 14, 15 and to regulate the addition of aminoarabinose and 2-hydroxymyristate to the lipid A. 16 We recently demonstrated the presence of phoP/phoQ in N. meningitidis 17 and its role in the virulence of the organism. 18 A phoP mutant of a meningococcal strain previously shown to be virulent in the mouse was completely avirulent and stimulated a strong, cross-protective immune response to a range of strains of neisseria. In light of the previous work of others in relation to phoP and salmonella, we propose that the phoP mutant may possess structurally altered LOS which contributes to the decreased toxicity of the organism but allows the molecule to retain its adjuvant effect. 19 It has been shown that the interaction of LOS with cells of the immune system leads to the production of a variety of pro-inflammatory mediators, required to stimulate the immune response and control infection. [20] [21] [22] Pathological effects occur when these responses are disregulated by high concentrations of LOS, leading ultimately to lethal shock. We propose that the phoP mutant of N. meningitidis previously described 18 shows a change in LOS leading to altered toxicity whilst retaining its adjuvant activity. In this study, we examine the capability of purified LOS from the wild-type and the phoP mutant to stimulate a pro-inflammatory response in human peripheral blood monocytes.
MATERIALS AND METHODS

Bacterial strains and plasmid
The N. meningitidis strain used in this study L91543 (C2a P1.2, ST-11, ET-37 complex; UK) was routinely grown on CBA plates (Columbia agar base, Oxoid, Bucks, UK, supplemented with 6% (v/v) defibrinated horse blood, TC supplies) and in Mueller-Hinton (MH) broth (Oxoid).
Plasmid pUS 2130 (28) is a pUC19-based plasmid with the ampicillin gene replaced by the aph gene. Regions flanking either side of the phoP gene were inserted on either side of the aph gene. Linearized plasmid pUS2130 was transformed into the meningococcus and confirmed by PCR and Southern blot analysis as previously described by Johnson et al. 17 
Preparation of LOS samples
Preparation of neisseria cells
LOS was extracted from the mutant and wild-type neisseria using a modification of the hot-phenol method originally described by Westphal and Jann. 23 Briefly, multiple streak plates were prepared from frozen stocks of bacteria on Columbia Blood Agar containing 6% defibrinated horse blood. Plates were incubated overnight (35°C, 4.5% CO 2 ) and morphology confirmed by Gram-staining.
Colonies were picked and spread over an assay plate of GC agar containing 1% IsovitaleX produce a confluent lawn of bacteria. After overnight incubation (35°C, 4.5% CO 2 ), colonies (confirmed by morphology) were added to 10 ml of buffer (40 mM Na 2 HPO 4 , 5 mM EDTA, pH 7) and heated for 30 min at 56°C in a water bath to inactivate the bacteria. After centrifugation (15 min, 2000 g), cells were resuspended in buffer (40 mM Na 2 HPO 4 , 5 mM EDTA, pH 7)at a ratio of 15 ml of the buffer per 1-1.5 g wet weight of cells. To this was added 6 mg of lysozyme per g wet weight. The mixture was incubated overnight at 4°C with mixing.
Extraction of LOS
The cell suspension prepared above was heated to 70°C and an equal volume of hot phenol (pre-heated to 70°C) was added. After thorough mixing, the suspension was incubated for 30 min in a 70°C water bath with constant agitation. The suspension was cooled in stages, first in a 30°C water bath, and subsequently in an ice bath to approximately 10°C. After centrifugation (30 min, 10°C at 10500 g), the water phase containing the LOS was removed. The phenol phase was re-extracted as above after mixing with the same volume of 70°C, pre-heated water. The water phases were combined and dialysed using 2000 MWCO dialysis tubing (Spectrum Laboratories Inc.,) against tap water for a minimum of 2 days in order to remove the phenol. After dialysis, the preparation was lyophilised and resuspended in about 30 ml of 10 mM MgCl 2 solution. DNase and RNase were added to a concentration of 50 µg/ml each, and incubated for 4 h at 37°C while mixing.
Proteinase K was added at a concentration of 50 µg/ml and incubation continued overnight (37°C). The mixture was ultracentrifuged for 3 h (10°C; 105,000 g), the pellet resuspended in 20 ml of pyrogen-free water and, after incubation at 4°C overnight, the preparation was again lyophilised. Eight different batches of LOS were prepared in this way, four each for the wild-type and mutant strains.
SDS-PAGE analysis
Lyophilised samples were resuspended in distilled water according to their dry weight to give an approximate 2 mg/ml concentration. A 20-µl aliquot of each sample was added to 20 µl of loading buffer (0.1 M Tris, 2% w/v SDS, 20% w/v sucrose, 1% v/v 2-mercaptoethanol and 0.001% bromophenol blue) and boiled for 5 min at 85°C. Samples were centrifuged at 7000 rpm for 15 s and kept on ice prior to loading. Bis-Tris Novex gels (Invitrogen; 4-12% 10-well) and NuPAGE MES SDS 20x running buffer (Invitrogen) were used. The gel was washed in running buffer and clamped into the Novex cell which was subsequently filled with running buffer. Aliquots (20 µl) of each sample were loaded into the wells of the gel and 3 µl of Novex Mark 12 wide-range protein standard was loaded into the end wells of the gel. The gel was run at 200 V and 120 mA for 45 min. The gel was fixed for 2 h in fixer (55% distilled water, 40% ethanol, 5% acetic acid) with constant agitation and then for 5 min in 0.7% periodic acid to oxidise the LOS. Three 10-min washes each of 500 ml distilled water followed fixing. The gel was silver stained for 10 min (115 ml distilled water, 28 ml 0.1 M NaOH, 1 g silver nitrate and 2 ml NH 3 OH) followed by three, 10-min washes in 500 ml distilled water. Bands were developed using a formaldehyde developer (0.5 ml 37% formaldehyde, 0.05 g citric acid in 1 l distilled water) until they became clear. Development was terminated by a 10% acetic acid solution. The gel was photographed using an Olympus Camedia E20-P camera and analysed using Image-J software version 1.32j (National Institutes of Health, USA).
MALDI-TOF
MALDI-TOF analyses were performed using a Voyager DE linear time of flight mass spectrometer (Applied Biosystems, Warrington, UK). Aliquots (1 µl) of matrix solution consisting of 2,5-dihydroxy benzoic acid at a concentration of 7 mg/ml in 20:80:0.1 acetonitrile:water:trifluoroacetic acid (LaberBio Labs, Sophia-Antipolis, France) were applied to a number of wells on the MALDI sample plate and allowed to dry. These were then analysed to obtain a blank profile for each well prior to the application of analyte. Aliquots (1 µl) of analyte in water were then applied, allowed to dry and investigated in negative mode using an accelerating potential of 20 kV. For each scan, 50 spectra were collected with laser intensity being varied in order to optimize signal strength. Where weak signal was produced, a further 1 µl aliquot of sample was applied to the sample well and the analysis repeated. Collected data were analysed after acquisition using proprietary software from the instrument manufacturer.
Cellular assays
Blood was obtained with full, informed, consent from healthy, laboratory personnel with full compliance with local ethical regulations. Fresh, venous blood anti-coagulated with sodium citrate (Sigma Chemicals, Poole, Dorset UK) was diluted with an equal volume of RPMI 1640 medium and layered over density gradient centrifugation medium (Lymphoprep, Nyegaard, Sweden). After centrifugation (400 g, 20 min) the mononuclear cells were harvested and washed twice (400 g, 5 min) in RPMI 1640. Cells were counted and resuspended at a concentration of 1.5 x 10 6 cells/ml in bicarbonate-buffered RPMI 1640 containing 10% fetal calf serum and 120 mM L-glutamine. For cytokine assays, 500 µl aliquots of the cell suspension were added to each well of a 24-well, flat-bottomed tissue culture plate and incubated for 2 h (37°C, 5% CO 2 ). After washing with warm medium, cells were stimulated with various concentrations of wild-type and phoP mutant LOS. After 24 h, the supernatants were harvested and analyzed for cytokine production using a human inflammation capture bead assay according to the manufacturer's instructions (Becton Dickinson, San Diego, CA, USA).
For assays investigating the effect of LOS on the redox status of cells, adherent monocytes were covered with phenol red free RPMI 1640 containing L-glutamine (200 mM), 5% fetal calf serum and 5-(and-6)-carboxy-2′,7′difluorodihydrofluorescein diacetate (10 µM DFFDA). Wells were supplemented with various concentrations of wild-type and phoP mutant LOS and incubated for 30, 60 or 90 min at 37°C. After incubation, the supernatant was removed and the cells harvested using cell dissociation medium. After washing in Facsflow, cells were analysed using a Becton Dickinson Facscan and Cellquest software (Becton Dickinson).
RESULTS
SDS-PAGE analysis
The purified LOS derived from the wild-type and phoP mutant strains were subjected to SDS-PAGE analysis and their intensity profiles analysed (Fig. 1) . The wildtype LOS showed one dominant species with a second, minor species (intensity ratio 1.9:1) whilst that of the phoP mutant showed these two species to be of equal prevalence (intensity ratio 1.25: 1).
MALDI-TOF
MALDI-TOF analysis was performed after nuclear magnetic resonance analysis indicated differences between the wild-type and mutant preparations. The MALDI-TOF mass spectra demonstrate clear differences in the relative expression of the different ionic species generated from the wildtype and phoP LOS ( Fig. 2A,B , respectively). Only the major peak at m/z 844 in Figure 4A also appeared in the sample wells containing matrix only as blanks. These data provide an initial qualitative indicator of LOS expression in the two preparations of LOS. Further work to identify specifically the species is underway. 
B Cytokine production by LOS stimulated peripheral blood monocytes
Having demonstrated biochemical differences between the wild-type and phoP LOS preparations as hypothesised, the biological activity of the compounds was examined. Peripheral blood monocytes were stimulated with a range of concentrations of LOS from either the wild-type or phoP mutant. These concentrations reflect those that might be found early in an infection or at a site removed from the point of infection (100-200 ng/ml) and those that might be found at the site of an established infection (1000-2000 ng/ml). After 24-h stimulation with either wild-type or phoP derived LOS, human monocytes showed similar patterns of production for IL-8, IL-6, TNF and IL-1β. At the lowest concentration of LOS, that derived from the phoP mutant was more potent than the wild-type at eliciting IL-8 and IL-6 production (Fig. 3A,B ). There was no significant difference between the two LOS samples with regard to the production of the other cytokines examined at this concentration. By contrast, at a concentration of 1 µg/ml, LOS derived from the wild-type elicited significantly higher levels of IL-8, IL-6, IL-1β and TNF than that from the phoP mutant ( Fig. 3A-E 
A B
C D E F reflect the fact that these cytokines are produced very early in a reaction and stimulate the production of other cytokines.
Production of free radicals
Freshly isolated monocytes were cultured for 30, 60 or 90 min with LOS derived from either the wild-type or the phoP mutant. Alteration in the redox status of the cell was measured by the oxidation of a carboxy derivative of difluorodihydrofluorescein diacetate (5-(and-6)-carboxy-2′,7′-difluorodihydrofluorescein diacetate (DFFDA). The maximum effect was observed after 60-min incubation. When stimulated with 100 ng/ml of either the wild-type or PhoP LOS, cells did not show any alteration in their redox status (assessed by a change in the percentage of cells showing positive fluorescence) when compared to control, unstimulated cells ( Fig. 4) . By contrast, they did show a change when stimulated with 1000 ng/ml of either wild-type or PhoP LOS. However, the increase observed in those cells stimulated with wild-type LOS was significantly greater than that shown by cells stimulated with PhoP LOS (50% and 25%, respectively; P < 0.005).
DISCUSSION
Lipo-oligosaccharide is a major component of the outer membrane of N. meningitidis and is a potent immunostimulatory molecule, which plays a major contribution to the virulence of the organism and the symptoms associated with toxic shock. We have previously demonstrated that a phoP mutant of N. meningitidis exhibits reduced virulence of the disease in a murine model but is capable of stimulating a cross-protective humoral response. 17, 18 This suggests that the mutant is still capable of stimulating an effective immune response but does not have the associated toxicity of the wild-type organism. These properties are, in part, due to the lipid A moiety of the LOS. Lipid A is a highly toxic molecule capable of eliciting a strong, pro-inflammatory response. 19 Typically, low levels of LOS (that might be found early in an infection) will stimulate the innate immune and acute phase responses indicated by production of IL-1, IL-6, IL-8 and TNF-α, amongst others. Along with complement activation, in the early stages of infection, these responses help eliminate the organism and stimulate a specific immune response. Much higher levels of LOS typically found in an established infection may result in pathological consequences leading ultimately to fatal shock. We have demonstrated that at low concentrations, the phoP mutant-derived LOS stimulated a pro-inflammatory cytokine response that was significantly higher than that elicited by the wild-type LOS. At the higher concentrations of LOS, the response was reversed and the wild-type LOS stimulated significantly higher levels of IL-6, IL-8, IL-1β and TNF-α compared to the phoP mutant LOS. The levels of cytokines were several times the magnitude of that elicited by the lower concentrations of either LOS. Only very low levels of IL-10 and IL-12 were observed in the cultures and may have been derived from contaminating dendritic cells (which are adherent in the first few hours in culture). These cells are stimulated by LPS to produce the very early cytokines (such as IL-10 and IL-12), which promote the production of the other key cytokines. 22 Interestingly, at the higher concentrations, the phoP mutant-derived LOS significantly stimulated the production of IL-10, a cytokine key to the development of a humoral immune response. This correlates with our in vivo studies in which the phoP mutant stimulated a cross-protective, IgG-dependent humoral response. 18 In addition to their ability to cause the release of proinflammatory cytokines, endotoxins stimulate mononuclear phagocytes causing them to undergo a respiratory burst leading to the destruction of any phagocytosed micro-organisms. 24 This production of oxygen (and nitrogen) radicals is influenced by the nature of the stimulus, the redox status of the cell and the local cytokine balance. In this study, we have demonstrated that LOS from the phoP mutant stimulates a significantly smaller respiratory burst when compared to that derived from the wild-type. This confirms the cytokine evidence suggesting that the phoP-derived LOS exhibits reduced toxicity compared to that from the wild-type. One suggested cause of the observed differences between wild-type and PhoP is variation in LOS isolation procedures. To this end, we have repeated these studies with other batches of LOS (from both the wild-type and mutant) and with human monocytic cells lines (data not shown) and have obtained statistically similar results.
It has long been known that changes in the structure of LPS alters its toxicity. 25 Others have demonstrated that PhoP affects the structure of LPS and its ability to elicit a toxic response. 14 In this study, SDS-PAGE analysis of the purified LOS showed a difference between the wildtype and the phoP mutant. Typically, lipid A preparations from a single species comprise a heterogeneous mix of major and minor species. 26 N. meningitidis typically expresses one dominant species. 27 In the current study, SDS-PAGE analysis clearly showed that the wildtype possessed one dominant species (~6 kDa from the gel), which was almost twice as common as the minor, smaller species. By contrast, the phoP mutant showed these two species at very similar concentrations. The relative decrease in the concentration of the ~6-kDa lipid A species in the phoP mutant may be related to the decreased ability of this LOS preparation to stimulate cytokine production and respiratory burst activity. Toxicity of LOS has been shown to be dependent upon the presence of phosphate groups in the disaccharide structure and the number, position and nature of the acyl residues. Several reports have demonstrated that in other organisms, the phoP/Q system is responsible for modification of lipid A structure which may be responsible for our observed alteration in toxicity. Interestingly, in a recent paper, Tzeng et al. 28 have shown that a group B mutant of N. meningitidis (misR/misS) made by inactivation of the two-component regulator NMB0595 demonstrated an alteration in the structure of the inner core of the LOS. They suggested that this mutant did not show alteration in its lipid A structure. However, their MALDI-TOF spectra clearly show a single dominant lipid A species in the wild-type (GlcNAc 2 C12:02 β-9OHC12:02 β-OHC14:02 P2 PEA2), whilst the mutant had equivalent concentrations of three species (GlcNAc 2 C12:02 β-9OHC12:02 β-OHC14:02 P2 PEA2; GlcNAc 2 C12:02 β-OHC12:02 β-OHC14:02 8P1 PEA1 and GlcNAc 2 C12:02 β-OHC12:02 β-OHC14:02 P2). We have shown similar relative differences in our preparations of wild-type and phoP LOS but have yet to identify them specifically.
Alterations in the chemical structure of lipid A species changes their spatial arrangement and, therefore, their ability to interact with the CD14 receptor, resulting in apparent differences in toxicity. 10 Changes in the relative concentrations of the different species within the LOS preparation may, therefore, account for our observed differences in toxicity. This also suggests that the gene which has been inactivated in our phoP/Q mutant is normally involved in in situ modification of the organism's LOS during growth.
